Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (TEVA)
NYSE:TEVA
Teva Pharmaceutical (TEVA) Financial Statements
6,149 Followers
Teva Pharmaceutical Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 3.85B | $ 3.88B | $ 3.66B | $ 3.88B | $ 3.60B |
| Gross Profit | $ 1.85B | $ 1.80B | $ 1.58B | $ 1.77B | $ 1.67B |
| EBIT | $ 75.00M | $ -914.00M | $ 2.00M | $ -855.00M | $ 418.00M |
| EBITDA | $ 358.00M | $ -614.00M | $ 306.00M | $ -549.00M | $ 739.00M |
| Net Income Common Stockholders | $ 894.00M | $ -863.00M | $ -207.00M | $ -1.22B | $ 56.00M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 2.25B | $ 2.67B | $ 2.14B | $ 2.80B | $ 2.23B |
| Total Assets | $ 42.09B | $ 43.09B | $ 43.46B | $ 44.01B | $ 44.25B |
| Total Debt | $ 20.30B | $ 21.02B | $ 21.04B | $ 21.56B | $ 21.62B |
| Net Debt | $ 18.05B | $ 18.35B | $ 18.89B | $ 18.76B | $ 19.39B |
| Total Liabilities | $ 34.58B | $ 31.95B | $ 34.84B | $ 35.31B | $ 34.73B |
| Stockholders Equity | $ 6.93B | $ 10.48B | $ 7.86B | $ 7.90B | $ 8.77B |
| Cash Flow | - | ||||
| Free Cash Flow | $ -144.00M | $ 205.00M | $ -284.00M | $ 831.00M | $ 421.00M |
| Operating Cash Flow | $ 5.00M | $ 324.00M | $ -145.00M | $ 973.00M | $ 543.00M |
| Investing Cash Flow | $ 184.00M | $ 302.00M | $ 181.00M | $ 168.00M | $ 147.00M |
| Financing Cash Flow | $ -576.00M | $ -55.00M | $ -706.00M | $ -711.00M | $ -440.00M |